Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock

January 02, 2024

Via Benzinga

3 Biotech Stocks at the Forefront of the Quest for Eternal Youth

January 02, 2024

Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today.

These two biotech stocks hold enormous potential.

Peering Into Recursion Pharmaceuticals's Recent Short Interest

January 01, 2024

Via Benzinga

2 Cathie Wood Stocks That Might Be Smart Buys Right Now

December 17, 2023

Don't rush to buy shares just yet.

Looking Into Recursion Pharmaceuticals's Recent Short Interest

December 06, 2023

Via Benzinga

This Stock Could Soar by 120%, According to Wall Street

November 22, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.

Recursion Pharmaceuticals: Q3 Earnings Insights

November 09, 2023

Via Benzinga

AI-Focused Drug Discovery Stocks Index Up 26% In December

December 29, 2023

On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before.

Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher

December 26, 2023

Via Investor's Business Daily

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

December 20, 2023

Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets.

From Recursion Pharmaceuticals

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

3 Genomics Stocks to Unlock the Future of Medicine

December 19, 2023

2024 is going to be a sizzler in the biopharma sector.

These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?

December 18, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week

December 17, 2023

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Topics Artificial Intelligence

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

December 16, 2023

Wood is moving away from fintech and Internet names like COIN stock. She's now favoring genomics and artificial intelligence companies.

Topics Artificial Intelligence

Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock

December 14, 2023

9 micro/small cap AI stocks are still in bubble mode advancing 14.8%, on average, last week. In comparison, the Global X Artificial Intelligence & Technology ETF was only up 0.5% and the iShares...

Topics Artificial Intelligence

These 9 Micro/Small Cap AI Stocks Continue In Bubble Mode

December 12, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Topics Artificial Intelligence ETFs

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week

December 11, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Topics Artificial Intelligence

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November

December 06, 2023

The top 9 micro- and small-cap AI stocks advanced by 53%, on average, in November.

Topics Artificial Intelligence

November Recap: Top 9 Micro/Small Cap AI Stocks Up +53%, On Average

December 03, 2023

Hewlett Packard Enterprise Posts Upbeat Earnings, Joins Foot Locker, NetApp And Other Big Stocks Moving Higher On Wednesday

Topics Artificial Intelligence

November 29, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Wednesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) moved higher during Wednesday’s session following...

Via Benzinga

Topics Stocks

Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.

November 26, 2023

Scaling up means having more power to bring to bear on core activities.

Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy.

Topics Artificial Intelligence

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth

November 23, 2023

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

November 22, 2023

Cathie Wood just gave the company a huge vote of confidence.

Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?

November 21, 2023

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

Unlocking AI investment opportunities in healthcare

November 16, 2023

Via MarketBeat

Topics Artificial Intelligence ETFs

Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock

November 13, 2023

Via Benzinga

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence

November 09, 2023

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.

Digitally enabled drug discovery for oncology has the potential to accelerate the delivery of new cancer therapies to patients. Drug discovery research collaboration may initiate up to seven oncology...

Topics Artificial Intelligence

Bayer and Recursion Focus Research Collaboration on Oncology

November 09, 2023

From Recursion Pharmaceuticals

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

November 09, 2023

With additional patient-centric data, compute power, and an exciting new focus for its Bayer collaboration, the company is accelerating the shift of biotech to techbio

From Recursion Pharmaceuticals, Inc.